2006
Treatment of Generalized Lichen Planus With Alefacept
Search citation statements
Paper Sections
Select...
46
3
0
0
Citation Types
0
19
0
1
Year Published
2006
2025
Publication Types
Select...
37
11
1
Relationship
0
49
Authors
Journals
Cited by 49 publications
(20 citation statements)
References 12 publications
0
19
0
1
“…Similarly, the dual effect on T cells of alefacept may be true to OLP, in which T-cell activation is the key of its immunopathogenesis (18). A dramatic response to alefacept therapy has been illustrated by Fivenson et al (21) in two patients with recalcitrant generalized and OLP. Moreover, in the small case series conducted by Chang et al, (22) alefacept may have conferred a modest therapeutic response in erosive LP.…”
Section: Alefaceptmentioning
confidence: 80%
“…Similarly, the dual effect on T cells of alefacept may be true to OLP, in which T-cell activation is the key of its immunopathogenesis (18). A dramatic response to alefacept therapy has been illustrated by Fivenson et al (21) in two patients with recalcitrant generalized and OLP. Moreover, in the small case series conducted by Chang et al, (22) alefacept may have conferred a modest therapeutic response in erosive LP.…”
Section: Alefaceptmentioning
confidence: 80%
“…A dramatic response to alefacept therapy has been illustrated by Fivenson et al. (21) in two patients with recalcitrant generalized and OLP. Moreover, in the small case series conducted by Chang et al., (22) alefacept may have conferred a modest therapeutic response in erosive LP.…”
Section: Alefaceptmentioning
confidence: 81%
“…In case reports about the sites of involvement in patients with GCLP, extensive extremity and trunk involvement has been observed [ 16 , 17 ]. In our study, we found that trunk and flexural region involvement was more common in patients with GCLP than in those with LCLP.…”
Section: Discussionmentioning
confidence: 99%
“…There is one report of a patient with refractory oral and cutaneous LP who experienced significant improvement after therapy with efalizumab [6]. Another report on the use of alefacept in two patients with LP showed a dramatic response of all skin lesions [7]. Etanercept is a fully human TNF-a receptor fusion protein that binds TNF-a with greater affinity than natural receptors.…”
Section: Discussionmentioning
confidence: 99%
